I. Introduction
Surgical resection is the current standard treatment for both primary and metastatic liver cancer. Depending on technique, either one of the two liver lobes is surgically removed (anatomical resection), or part of a lobe is removed (partial resection). Surgical resection is associated with high interoperative blood loss, with mean blood loss between 600 mL and 1300 mL [1], [2], with 28 to 47% of the patients requiring blood transfusion [1], [3]. Several studies have shown that blood loss correlates adversely with length of hospital stay, complication rate, and patient survival [4], [5]. Especially when transfusion is required, patient prognosis is affected detrimentally, probably due to immunosuppression [6]. Further reduction in interoperative blood loss is therefore advocated by many surgeons.